Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06934577 · ClinicalTrials.gov registry record · NA

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2

A NA study of Glaucoma and Eye Diseases, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
1
Study location

NCT06934577 is a NA study of Glaucoma and Eye Diseases that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 900 participants, roughly in line with the 901-participant average among 92 other Glaucoma trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06934577, a NA study of Glaucoma and Eye Diseases, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
1
Study location

Study Summary

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.

Interventions

  • OTHER Standard optometric examination
  • OTHER Technology enhanced eye disease detection protocol

Study Locations (1)

Michigan

  • Hamilton Optometry Clinic - Flint

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2025-12-04
Est. Completion 2030-08
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06934577

The ClinicalTrials.gov registry entry for NCT06934577 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 901-participant average among 92 other Glaucoma trials with a reported enrollment target. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Standard optometric examination is the first listed.

NCT06934577 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06934577 about?

NCT06934577 is a clinical study titled "Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2". To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.

What is the current status of trial NCT06934577?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2025-12-04. Estimated completion is 2030-08.

What conditions does trial NCT06934577 study?

This clinical trial studies the following conditions: Glaucoma, Eye Diseases, Visual Impairment.

What interventions are being tested in trial NCT06934577?

The interventions under investigation include: Standard optometric examination (OTHER), Technology enhanced eye disease detection protocol (OTHER).

Who is sponsoring clinical trial NCT06934577?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06934577 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.